Compare A & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | A | MDLN |
|---|---|---|
| Founded | 1999 | 1966 |
| Country | United States | United States |
| Employees | N/A | 45000 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.8B | 37.4B |
| IPO Year | 1999 | N/A |
| Metric | A | MDLN |
|---|---|---|
| Price | $118.07 | $41.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 23 |
| Target Price | ★ $161.47 | $50.48 |
| AVG Volume (30 Days) | 1.5M | ★ 4.6M |
| Earning Date | 05-27-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | ★ 3.16 | N/A |
| EPS | ★ 1.07 | N/A |
| Revenue | ★ $4,472,000,000.00 | N/A |
| Revenue This Year | $8.45 | $10.88 |
| Revenue Next Year | $6.13 | $7.69 |
| P/E Ratio | ★ $109.82 | $658.75 |
| Revenue Growth | ★ 6.43 | N/A |
| 52 Week Low | $106.55 | $38.50 |
| 52 Week High | $160.27 | $50.88 |
| Indicator | A | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 53.49 | 36.42 |
| Support Level | $115.76 | $38.50 |
| Resistance Level | $130.54 | $44.11 |
| Average True Range (ATR) | 3.32 | 1.67 |
| MACD | 0.01 | -0.45 |
| Stochastic Oscillator | 54.75 | 15.74 |
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.